Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck

BACKGROUND: Concurrent chemoradiotherapy is an established component of the nonoperative management of locally advanced head and neck squamous cell carcinoma (HNSCC), but the standard dose of 100 mg/m(2) cisplatin every 3 weeks is associated with clinically significant toxicity. Interest in a more t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Bauml, Joshua M, Vinnakota, Ravi, Anna Park, Yeun-Hee, Bates, Susan E, Fojo, Tito, Aggarwal, Charu, Limaye, Sewanti, Damjanov, Nevena, Di Stefano, Jessica, Ciunci, Christine, Genden, Eric M, Wisnivesky, Juan P, Ferrandino, Rocco, Mamtani, Ronac, Langer, Corey J, Cohen, Roger B, Sigel, Keith
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6510226/
https://ncbi.nlm.nih.gov/pubmed/30239887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy133
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados